Cargando…

Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates

Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (347...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castor, Mei L., Whitney, Cynthia G., Como-Sabetti, Kathryn, Facklam, Richard R., Ferrieri, Patricia, Bartkus, Joanne M., Juni, Billie A., Cieslak, Paul R., Farley, Monica M., Dumas, Nellie B., Schrag, Stephanie J., Lynfield, Ruth
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637368/ https://www.ncbi.nlm.nih.gov/pubmed/19223967 http://dx.doi.org/10.1155/2008/727505

Ejemplares similares

Methicillin-Resistant Staphylococcus aureus at Canoe Camp
por: Como-Sabetti, Kathryn, et al.
Publicado: (2006)

982. Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017
por: Thielen, Beth, et al.
Publicado: (2018)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

715. Increase in Reported Respiratory Syncytial Virus Cases Among Adults in the Minneapolis-St. Paul Metropolitan Area, 2014–2018
por: Como-Sabetti, Kathryn, et al.
Publicado: (2018)

685. Correlation Between Hospitalized Influenza and Group A Streptococcus Infections in Minnesota, 2010–2016
por: Arogbokun, Olufunmilayo, et al.
Publicado: (2018)

1925. Prevalence of SARS-CoV-2 Infection in Immunocompromised Patients Following Receipt of Tixagevimab/Cilgavimab
por: Lim, Sarah, et al.
Publicado: (2022)

Invasive Group B Streptococcal Disease in the Elderly, Minnesota, USA, 2003–2007
por: Kothari, Neelay J., et al.
Publicado: (2009)

Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use
por: Kiang, Karen M., et al.
Publicado: (2005)

186. Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021
por: Meyer, Stephanie, et al.
Publicado: (2021)

Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
por: Buck, Jessica M., et al.
Publicado: (2005)

Comparison of Respiratory Pathogen Detections from Routine Hospital Testing and Expanded Systematic Testing from the Minnesota Severe Acute Respiratory Illness Surveillance Program, 2015–2016
por: Steffens, Andrea, et al.
Publicado: (2017)

Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA
por: Koeck, Mackenzie, et al.
Publicado: (2019)

Rifampin-resistant Meningococcal Disease
por: Rainbow, Jean, et al.
Publicado: (2005)

787 Respiratory Pathogen Detection in Cases of Severe Acute Respiratory Illness (SARI) Among Hospitalized Patients at Two Metro-Area Hospitals, Minnesota, 2013-2014
por: Friedlander, Hannah, et al.
Publicado: (2014)

Perinatal Group B Streptococcal Disease Prevention, Minnesota
por: Morin, Craig A., et al.
Publicado: (2005)

ICD-9 code reporting among patients from the Minnesota SARI surveillance program
por: Steffens, Andrea, et al.
Publicado: (2017)

Antibiotic prescribing for adults with group A streptococcal bacteremia in a large healthcare system
por: Gillins, David A., et al.
Publicado: (2023)

Vaccine effectiveness against influenza-associated hospitalization among children aged < 13 years using a hospital-based surveillance system in Minnesota, 2013 – 2016
por: Fowlkes, Ashley, et al.
Publicado: (2017)

Group B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types
por: Shabayek, Sarah, et al.
Publicado: (2021)

1718 Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012
por: Van Beneden, Chris, et al.
Publicado: (2014)

First Identified Cases of SARS-CoV-2 Variant B.1.1.7 in Minnesota — December 2020–January 2021
por: Firestone, Melanie J., et al.
Publicado: (2021)

Serotype IV and Invasive Group B Streptococcus Disease in Neonates, Minnesota, USA, 2000–2010
por: Ferrieri, Patricia, et al.
Publicado: (2013)

Sentinel Surveillance: A Reliable Way To Track Antibiotic Resistance in Communities?
por: Schrag, Stephanie J., et al.
Publicado: (2002)

1842. Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia
por: Salam, Madison E, et al.
Publicado: (2022)

Invasive Group A Streptococcal Infection in Older Adults in Long-term Care Facilities and the Community, United States, 1998–2003(1)
por: Thigpen, Michael C., et al.
Publicado: (2007)

Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes.
por: Glass, Nina E, et al.
Publicado: (2005)

Invasive Group A Streptococcal Disease in Nursing Homes, Minnesota, 1995–2006
por: Rainbow, Jean, et al.
Publicado: (2008)

First Identified Cases of SARS-CoV-2 Variant P.1 in the United States — Minnesota, January 2021
por: Firestone, Melanie J., et al.
Publicado: (2021)

Factors associated with SARS-CoV-2 and community-onset invasive Staphylococcus aureus coinfection, 2020
por: Jackson, Kelly, et al.
Publicado: (2023)

Notes from the Field: Increase in Pediatric Invasive Group A Streptococcus Infections — Colorado and Minnesota, October–December 2022
por: Barnes, Meghan, et al.
Publicado: (2023)

1337 Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Non-Pregnant Adults
por: Pitts, Samantha, et al.
Publicado: (2014)

1430. Outbreak Clusters of Invasive Group A Streptococcus Associated with Wound Care in Long-term Care Facilities
por: Zipprich, Jennifer, et al.
Publicado: (2023)

Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States
por: Pitts, Samantha I, et al.
Publicado: (2018)

Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review
por: Le Doare, Kirsty, et al.
Publicado: (2017)

Invasive Group A Streptococcal Disease: Risk Factors for Adults
por: Factor, Stephanie H., et al.
Publicado: (2003)

Detection of Influenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013–2016
por: Thielen, Beth K, et al.
Publicado: (2018)

Prospective Evaluation of Xpert® Xpress Strep A Automated PCR Assay vs. Solana® Group A Streptococcal Nucleic Acid Amplification Testing vs. Conventional Throat Culture
por: Ferrieri, Patricia, et al.
Publicado: (2021)

Antibiotic resistance patterns of group B streptococcal clinical isolates.
por: Simoes, Jose A, et al.
Publicado: (2004)

Evaluating antibiotic regimens for streptococcal toxic shock syndrome in children
por: Zhang, Haixia, et al.
Publicado: (2023)

Risk Factors for Pediatric Invasive Group A Streptococcal Disease
por: Factor, Stephanie H., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dfvkmt36jqrchi1ppg5d94aq6p